Skip to main content
Equibles

Cresset Asset Management, LLC

Position in NUVB — Nuvation Bio Inc.

CIK 1761013 Chicago, IL
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$687,507
+$168,246 QoQ
Shares Held
121,040
0.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cresset Asset Management, LLC holds $108,155,066 across 44 Biotechnology names. NUVB ranks #18 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 736,708 $52,048,420
2 HALO
Halozyme Therapeutics, Inc.
 260,937 $20,423,538
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 7,926 $3,937,081
4 EXEL
Exelixis, Inc.
 70,918 $3,858,648
5 HRMY
Harmony Biosciences Holdings, Inc.
 102,479 $3,731,260
6 TVTX
Travere Therapeutics, Inc.
 35,433 $2,012,948
7 MRNA
Moderna, Inc.
 28,359 $1,985,980
8 PVLA
Palvella Therapeutics, Inc.
 11,629 $1,777,143

All Filings in NUVB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $687,507 121,040
2026-03-31 $519,261 121,040
2025-12-31 $1,063,014 118,640
2025-09-30 $531,653 143,690
2025-06-30 $280,195 143,690
2025-03-31 $244,316 138,816
2024-12-31 $362,917 136,435
2024-09-30 $307,524 134,290
2024-06-30 $371,278 127,150
2024-03-31 $462,826 127,150
2023-12-31 $191,845 127,050
2023-09-30 $171,805 128,213
2023-06-30 $231,935 128,853
2023-03-31 $211,069 127,150
2022-12-31 $244,128 127,150
2022-09-30 $439,152 196,050
2022-06-30 $635,202 196,050
2022-03-31 $1,031,223 196,050
2021-12-31 $1,666,425 196,050
2021-09-30 $1,859,277 187,050
2021-06-30 $1,741,435 187,050
2021-03-31 $1,327,672 127,050